International Isotopes posts 10% increase in Q1 revenue

2021 01 26 19 34 6212 Businessman Plan Graph 400

Radioisotope manufacturer International Isotopes has posted increased revenue for its 2023 first quarter.

For the period (end-March 31), the company reported revenue of $3.1 million, up 10% from $2.8 million in the first quarter of 2022. It attributed the uptick to increases in its radiochemical and nuclear medicine segments. However, the firm also had a net loss of $148,054, compared with net income of $1.2 million for the same period in 2022.

The company posted a revenue increase of 8% in its radiochemical products segment for the period compared with the same period last year, which it attributed to an increase in sales of its sodium iodide I-131 drug. It also reported a revenue increase of 16% from its nuclear medicine products segment compared to the first quarter of 2022.

Page 1 of 436
Next Page